𝔖 Bobbio Scriptorium

✦ LIBER ✦

Secukinumab’s time to psoriasis response on patient-reported psoriasis symptoms (ERASURE study)

Book ID: 122129417
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 49 KB
Volume: 70
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2014.01.782

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secukinumab versus placebo or etanercept

Secukinumab versus placebo or etanercept on time to response on patient-reported psoriasis symptoms of pain, itching, and scaling (FIXTURE study)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Secukinumab impact on patient-reported p

Secukinumab impact on patient-reported psoriasis symptoms of pain, itching, and scaling compared to placebo and etanercept (FIXTURE Study)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Secukinumab efficacy in relationship wit

Secukinumab efficacy in relationship with response to previous biologic psoriasis therapy: A subanalysis from the ERASURE Study

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Secukinumab efficacy in subjects with mo

Secukinumab efficacy in subjects with moderate to severe plaque psoriasis: A pooled analysis of patient-reported symptoms (pruritus, pain, and scaling) in 2 phase 3 clinical studies (ERASURE and FIXTURE)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Secukinumab treatment shows a neutral im

Secukinumab treatment shows a neutral impact on the lipid profile of patients with moderate to severe plaque psoriasis in a dose-ranging study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Impact of sustained robust response on p

Impact of sustained robust response on patient-reported outcomes for adalimumab-treated patients with moderate to severe psoriasis: Subanalysis of REVEAL

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB